These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19834469)

  • 1. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
    Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
    Obesity (Silver Spring); 2010 Jun; 18(6):1079-84. PubMed ID: 19834469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients.
    Ferretti G; Bacchetti T; Busni D; Rabini RA; Curatola G
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2957-62. PubMed ID: 15181084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
    Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.
    Bacchetti T; Campanati A; Ferretti G; Simonetti O; Liberati G; Offidani AM
    Br J Dermatol; 2013 May; 168(5):984-9. PubMed ID: 23614561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1.
    Ferretti G; Bacchetti T; Campanati A; Simonetti O; Liberati G; Offidani A
    Br J Dermatol; 2012 Jan; 166(1):204-7. PubMed ID: 21790517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective action of Ilex paraguariensis extract against free radical inactivation of paraoxonase-1 in high-density lipoprotein.
    Menini T; Heck C; Schulze J; de Mejia E; Gugliucci A
    Planta Med; 2007 Sep; 73(11):1141-7. PubMed ID: 17823869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orlistat increases serum paraoxonase activity in obese patients.
    Audikovszky M; Pados G; Seres I; Harangi M; Fülöp P; Katona E; Illyés L; Winkler G; Katona EM; Paragh G
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):268-73. PubMed ID: 17134960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
    Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
    Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
    Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
    Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
    Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
    Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G; Bacchetti T; Marotti E; Curatola G
    Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins.
    Loued S; Isabelle M; Berrougui H; Khalil A
    Life Sci; 2012 Jan; 90(1-2):82-8. PubMed ID: 22067439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels.
    Yesilbursa D; Serdar Z; Serdar A; Sarac M; Coskun S; Jale C
    Int J Obes (Lond); 2005 Jan; 29(1):142-5. PubMed ID: 15467775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.